Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

FDA-cleared EsoGuard/EsoCheck screening, Medicare coverage catalysts, Q3 results, VA contract and risks. Click here to read.

The Skeletal Dysplasia Market is expanding, driven by advancements in gene sequencing and orphan drug incentives. Key ...

EYATH (Thessaloniki Water Supply & Sewerage Company S.A., the public utility providing water and wastewater services to over ...

Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make ...

Here are Cathie Wood’s latest moves.

As part of its ongoing efforts to combat brucellosis, a serious and often neglected disease endemic to many low- and ...

Robots for specific blue collar tasks in difficult, repetitive and harsh environments are delivering value now in terms of quality, safety, cost and process efficiencies.

Hexagon is flagging Saudi Arabia’s Vision 2030 and the government’s push to become a ‘minerals superpower’ as a game-changing ...